While high PDPN expression was predominantly found in lymphatic endothelium and often utilised as a marker for lymphatic vessels [106], elevated PDPN expression has been reported in CAFs and associated with poor outcomes in various cancer types, including lung [107], breast [108], and pancreatic cancers [109]. The gene discussed is PDPN; the disease is familial pancreatic carcinoma.